Skip to main content
Erschienen in: Neurological Sciences 3/2022

Open Access 08.08.2021 | Original Article

Assessing mood and cognitive functioning in acute stroke: clinical usability of a Visual Analogue Mood Scale (VAMS)

verfasst von: Fabrizio Pasotti, Sabrina Serranò, Edoardo Nicolò Aiello, Chiara Gramegna, Matteo Querzola, Marcello Gallucci, Giuseppe Micieli, Allesandra Bollani, Elio Clemente Agostoni, Gabriella Bottini

Erschienen in: Neurological Sciences | Ausgabe 3/2022

Abstract

Background

Patients suffering from stroke in the acute/post-acute phases often present with depressive mood — which negatively impacts on patients’ prognosis. However, psychometric evaluation of mood in acute stroke patients may be challenging due to cognitive deficits. Tools investigating emotional states via a vertical analogue line may overcome language/visuo-spatial disorders. This study thus aimed at (a) investigating the clinical usability of a Visual Analogue Mood Scale (VAMS) in acute stroke patients and (b) investigating the interplay between mood and cognition in this population.

Methods

Forty-one acute stroke patients were compared to 41 age-, education- and sex-matched healthy participants (HPs) on the VAMS and on cognitive measures (mental performance in acute stroke, MEPS). A control line bisection (LB) task was administered to control for potential visuo-spatial deficits in patients.

Results

Patients reported higher depression levels than HPs (lower VAMS scores); this between-group difference stayed significant when covarying for LB scores. MEPS scores discriminated patients from HPs; among cognitive measures, only the Clock drawing test (CDT) was positively associated with VAMS scores. Lesion side did not affect patients’ mood state; however, disease duration was inversely related to VAMS scores.

Discussion

The VAMS proved to be a suitable tool for assessing mood in acute stroke patients, as being independent from post-stroke cognitive sequelae. The CDT might represent an adequate measure of depression-induced, post-stroke cognitive efficiency decrease. Mood disorders might occur and thus should be adequately addressed also in post-acute phases — likely due to longer hospitalization times and regression of anosognosic features.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

A stroke occurs when the blood flow directed to the brain is suddenly interrupted by embolic, ischemic or hemorrhagic events, leading to brain damage. Cerebral ischemia is reckoned to be the most frequent cause of stroke (87%) [28].
According to the World Health Organization, 15 million people suffer from stroke worldwide each year [29].
Between 2015 and 2018, stroke incidence in the USA has been estimated at 7.6 million (≥ 20 years), with an expected increase of 3.4 million by the year 2030 (≥ 18 years) when compared to the year 2012 [28]. Advanced age being one of the main risk factors, its exponential growth may determine a 50% increase in the death toll by 2030 when compared to 2012 [28].
Stroke is also one of the leading causes of death and long-term disability [28].
Among both short- and long-term functional sequelae, a stroke can cause several cognitive and mood disorders — depending on brain structures affected, as well as on the features of the lesion [6, 2223].
Neglect, aphasia, apraxia and dysexecutive symptoms are highly frequent neuropsychological consequences [5, 6, 9], whereas depression may arise within the mood sphere [2123] and mood symptoms in general are considered a potentially direct consequence of stroke [21, 22].
As mood and cognition dysfunctions represent negative prognostic factors for both recovery [5, 11, 24] and survival [16], it is crucial to provide neuropsychological assessment, even at an early stage [25].
Typically, in the acute stage of stroke, patients are bedridden and fatigued and show fluctuating levels of arousal and awareness [8]. Therefore, short-lived although specific screening tools appear to be more reliable [25].
Given the frequent association between depression and cognitive dysfunctions in stroke [1222] the present study aimed at the following: (a) exploring the interplay between mood and cognition in a clinic-based cohort of patients in the acute post-stroke phase; (b) investigating the clinical usability of a mood scale that accounts for cognitive dysfunctions [12].

Methods

Participants

A convenience cohort of forty-one stroke patients was consecutively recruited at Stroke Units/Neurology Sections of four hospitals in Northern Italy: ASST Grande Ospedale Metropolitano Niguarda (Milan); Fondazione Istituto Neurologico Casimiro Mondino (Pavia); Ospedale Civile di Voghera; Humanitas Clinical and Research Hospital (Rozzano). Inclusion criteria were (a) ischemic or hemorrhagic stroke supported by cerebral computerized tomography/magnetic resonance imaging; (b) acute phase (<30 days from the event); (c) age >18 years. Patients had no history of psychiatric or other neurological co-morbidities, drug abuse, and multi-organ impairments. Severe aphasia with impaired comprehension (e.g., global aphasia) and/or severe disorders of consciousness were addressed as further exclusion criteria — as preventing from assessing patients cognition and mood.
The control group consisted of 41 age-, education- and sex-matched healthy participants (HPs) — i.e., with no history of neurological, psychiatric or severe internal conditions. The Mini-Mental State Examination [1415] was administered to HPs to rule out cognitive impairment.
Participants were native Italian speakers and had normal or corrected-to-normal vision.
Participants provided written informed consent before being enrolled. The study was approved by the local Research Ethics Committee and conducted according to the Declaration of Helsinki.

Materials

Cognitive assessment

Cognition was assessed via the mental performance in acute stroke (MEPS) [18], a cognitive screener developed to assess both instrumental and non-instrumental domains in patients suffering from stroke in the acute stages. The MEPS encompasses a set of 14 both verbal and non-verbal tasks evaluating orientation (temporal, TO; spatial, SO), language (Order comprehension, OC; Reading and comprehension of sentence, RCS; Words repetition, WR; Picture naming, PN), memory (Digit span, DS; Immediate visual memory, IVM), praxis (Ideomotor apraxia, IdeomA; Ideative apraxia, IdeatA) and visuo-spatial abilities (Segments discrimination, SD; Visual exploration and attention, VEA; Clock drawing test, CDT) and abstraction (Similarity judgments, SJ).

Mood assessment

Mood was assessed via a visual analogue scale (Visual Analogue Mood Scale; VAMS) [1227]. The VAMS consists of a 180-mm line having two circles at its respective ends that represent two opposite moods — the upper circle containing a stylized “happy” face, the lower a “sad” one. The VAMS thus allows measuring euthymia/dysthymia along a continuum.
As being a non-verbal, self-reported and rapid tool, it can be indicated for people with language difficulties — such as post-stroke patients [6]. Moreover, to prevent from any potential stroke-related attentional/representational/visuo-spatial deficit affecting patients’ performance, VAMS stimuli were conveniently structured vertically [27].
Participants were asked to draw a mark with the pen at the point that corresponded to his/her mood at that specific moment.
To ensure reliability in responses, the mean of 3 consecutively administered measures was regarded as the outcome.

Line bisection task

In order to control for systematic biases in VAMS scores due to potential attentional/representational/visuo-spatial deficits (e.g., neglect), a vertical line-bisection (LB) task was administered. The LB task consisted of a 180-mm-long vertical straight line having two empty circles at their respective ends (one for each end). The subject was asked to mark with a pen the middle of the line. To ensure reliability in responses, the mean of 3 consecutively administered measures was regarded as the outcome.

Statistical analyses

Normality checks were performed on raw variables both descriptively (by assessing skewness and kurtosis values, judged as abnormal if > |1| and |3|, respectively) and graphically (by visually inspecting histograms and Q-Q plots) [7, 13]. Associations of interest between continuous variables were assessed via either Pearson’s or Spearman’s techniques; between-group comparisons were explored via either Mann-Whitney and Kruskal-Wallis tests or t-tests and analyses of variance.
Clinical judgments on MEPS total and sub-test scores were drawn according to the Equivalent Scores (ESs) method [3, 18].
Significance level was set at .05. Analyses were performed via SPSS 27 [10].

Results

Background, clinical and psychometric measures of participants are summarized in Table 1. Groups were matched for age (t(59.02)=.16; p=.874) and education (t(80)=−.45; p=.651). Male/female ratio was balanced in each group (χ2(1)=.05; p=.822). Global cognition (MEPS total score) was not influenced by lesion side (χ2(2)=3.2; p=.205).
Table 1
Participants’ background, clinical and psychometric features
 
N
Sex
(F/M)
Age
(years)
Education
(years)
Days from onset
Lesion side
(L/R/B)
VAMS
LB
MEPS
total
Patients
41
24/17
64.2 ± 11.4
(45–90)
9.2 ± 4
(1–18)
4.2 ± 2.6
(1–10)
16/17/8
105.2 ± 54.2
(5.3–174)
92.3 ± 6.4
(78.3–105.7)
73.3 ± 6.8
(54–81.8)
HPs
41
25/16
63.9 ± 5.7
(55–76)
9.6 ± 3.3
(5–13)
128.1 ± 36.7
(25.7–173.3)
89 ± 3.2
(82.3–94.3)
79.8 ± 1.8
(74.4–82)
Notes: HPs, healthy participants; F, female; M, male; L, left; R, right; B, bilateral; VAMS, Visual Analogue Mood Scale; LB, line bisection task; MEPS, mental performance in acute stroke
HPs performed better than patients on both MEPS total (z=−5.61; p<.001) and sub-tests scores — TO (z=−4.73; p<.001), SO (z=−3.9; p<.001), OC (z=−2.53; p=.012), SD (z=−3.8; p<.001), RCS (z=−2.96; p=.003), IVM (z=−2.97; p=.003), WR (z=−2.04; p=.042), CDT (z=−3.65; p<.001), SJ (z=−4.73; p<.001), and PN (z=−3.35; p=.001). No significant between-group differences were detected with regard to DS, VEA, IdeomA and IdeatA. 51.2% of patients (N=21) scored below the cut-off on total-MEPS.
Neither in patients nor in HPs, sex, age or education was found to be associated with VAMS scores. When compared to HPs, patients reported lower VAMS (t(70.26)=−2.24, p=.029) and higher LB (t(58.84)=3.02, p=.004) scores. The between-group difference in VAMS scores stayed significant even when covarying for LB scores (F(1,79)=7.27; p=.009).
The association between VAMS scores and cognitive measures possibly affecting the execution of the task (i.e., MEPS total, SD, RCS, AM, CDT) was tested in both groups. Patients’ VAMS scores proved to be positively related to the performance on the CDT (rs(41)=.34; p=.027), whereas no other significant associations were detected.
No differences were found in patients’ VAMS scores between those who performed below (ES=0) and above (ES≥1) total-MEPS (t(39)=−1.58; p=.123) and CDT (t(39)=−.65; p=.523) cut-off values.
Patients who scored above 90 (“euthymic”) at the VAMS had been hospitalized for a shorter period of time (M=3.27; SD=1.5) when compared (t(17.24)=17.24; p=.008) to those who scored below 90 (“dysthymic”; M=5.9; SD=3.3). Moreover, a negative association was found between days from onset and VAMS scores (r(39)=−.52; p=.001).

Discussion

The VAMS appears to be a feasible tool for assessing emotional status (sadness) in patients with stroke independently of specific attentional/representational/visuo-spatial deficits. The correlation between the CDT and VAMS scores might be due to a post-stroke global cognitive dysfunction [19].
Our results also support the hypothesis that the occurrence of depressive symptoms is not lesion-side specific [1722].
In addition, the correlation between the CDT and VAMS scores suggests that the CDT is an adequate task for assessing cognition in acute/post-acute stroke patients with mood disorders [20].
An inverse correlation between VAMS scores and the number of days from stroke onset was also found, suggesting that the increasing awareness of the disease [26], together with the burden due to the prolonged hospitalization, negatively influences patients’ mood. This finding further supports the relevance of mood assessment also in post-acute stroke patients.
The present work is not free of limitations.
First, the VAMS was not put into relation with other quantitative/qualitative measures of depressive symptoms — this preventing from assessing its convergent validity as well as its sensitivity and specificity. Thereupon, further studies are undoubtedly needed in order to provide an in-depth analysis of VAMS both psychometric and diagnostic properties. However, it has to be noted that even gold-standard mood scales might be inefficient in detecting mood disorders in this population [4]. Similarly, should the VAMS be compared to clinical judgments, this comparison might suffer from subjectivity in ratings — which would increase due to intervening influences of the acute phase.
Moreover, it is worth noting that patients were not classified according to post-stroke cognitive syndromic nosography (e.g., aphasia, neglect). However, the fact that lesion side did not affect mood levels might, at least to an extent, rule out the influence of domain-specific cognitive impairment on VAMS performances.

Acknowledgements

The authors are grateful to all participants.

Declarations

Ethical approval

This study was conducted in accordance with the Declaration of Helsinki.

Conflict of interest

The authors declare no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

e.Med Neurologie

Kombi-Abonnement

Mit e.Med Neurologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes, den Premium-Inhalten der neurologischen Fachzeitschriften, inklusive einer gedruckten Neurologie-Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat Arruda JE, Stern RA, Somerville JA (1999) Measurement of mood states in stroke patients: validation of the visual analog mood scales. Arch Phys Med Rehabil 80:676–680CrossRef Arruda JE, Stern RA, Somerville JA (1999) Measurement of mood states in stroke patients: validation of the visual analog mood scales. Arch Phys Med Rehabil 80:676–680CrossRef
2.
Zurück zum Zitat Barrows PD, Thomas SA (2018) Assessment of mood in aphasia following stroke: validation of the Dynamic Visual Analogue Mood Scales (D-VAMS). Clin Rehabil 32:94–102CrossRef Barrows PD, Thomas SA (2018) Assessment of mood in aphasia following stroke: validation of the Dynamic Visual Analogue Mood Scales (D-VAMS). Clin Rehabil 32:94–102CrossRef
3.
Zurück zum Zitat Capitani E, Laiacona M (2017) Outer and inner tolerance limits: their usefulness for the construction of norms and the standardization of neuropsychological tests. Clin Neuropsychol 31:1219–1230CrossRef Capitani E, Laiacona M (2017) Outer and inner tolerance limits: their usefulness for the construction of norms and the standardization of neuropsychological tests. Clin Neuropsychol 31:1219–1230CrossRef
4.
Zurück zum Zitat Costantini M, Musso M, Viterbori P, Bonci F, Del Mastro L, Garrone O, Venturini M, Morasso G (1999) Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale. Supportive Care in Cancer 7:121–127CrossRef Costantini M, Musso M, Viterbori P, Bonci F, Del Mastro L, Garrone O, Venturini M, Morasso G (1999) Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale. Supportive Care in Cancer 7:121–127CrossRef
5.
Zurück zum Zitat Esposito, E., Shekhtman, G., Chen, P. (2020). Prevalence of spatial neglect post-stroke: a systematic review. Annals of Physical and Rehabilitation Medicine. Esposito, E., Shekhtman, G., Chen, P. (2020). Prevalence of spatial neglect post-stroke: a systematic review. Annals of Physical and Rehabilitation Medicine.
6.
Zurück zum Zitat Ferro JM (2001) Hyperacute cognitive stroke syndromes. J Neur 248:841–849CrossRef Ferro JM (2001) Hyperacute cognitive stroke syndromes. J Neur 248:841–849CrossRef
7.
Zurück zum Zitat Ghasemi A, Zahediasl S (2012) Normality tests for statistical analysis: a guide for non-statisticians. Int J Endocrinol Metab 10:486CrossRef Ghasemi A, Zahediasl S (2012) Normality tests for statistical analysis: a guide for non-statisticians. Int J Endocrinol Metab 10:486CrossRef
8.
Zurück zum Zitat Hannay HJ, Howieson DB, Loring DW, Fischer JS, Lezak MD (2004) Neuropathology for neuropsychologists. Neuropsychological Assessment 4:157–194 Hannay HJ, Howieson DB, Loring DW, Fischer JS, Lezak MD (2004) Neuropathology for neuropsychologists. Neuropsychological Assessment 4:157–194
9.
Zurück zum Zitat Hoffmann M (2001) Higher cortical function deficits after stroke: an analysis of 1,000 patients from a dedicated cognitive stroke registry. Neurorehabil Neural Repair 15:113–127CrossRef Hoffmann M (2001) Higher cortical function deficits after stroke: an analysis of 1,000 patients from a dedicated cognitive stroke registry. Neurorehabil Neural Repair 15:113–127CrossRef
10.
Zurück zum Zitat IBM Corp. (2020). IBM SPSS Statistics for Windows, Version 27.0. Armonk, NY: IBM Corp. IBM Corp. (2020). IBM SPSS Statistics for Windows, Version 27.0. Armonk, NY: IBM Corp.
11.
Zurück zum Zitat Kalra L, Perez I, Gupta S, Wittink M (1997) The influence of visual neglect on stroke rehabilitation. Stroke 28:1386–1391CrossRef Kalra L, Perez I, Gupta S, Wittink M (1997) The influence of visual neglect on stroke rehabilitation. Stroke 28:1386–1391CrossRef
12.
Zurück zum Zitat Kauhanen ML, Korpelainen JT, Hiltunen P, Brusin E, Mononen H, Maatta R, Nieminen P, Sotaniemi KA, Myllyla VV (1999) Poststroke depression correlates with cognitive impairment and neurological deficits. Stroke 30:1875–1880CrossRef Kauhanen ML, Korpelainen JT, Hiltunen P, Brusin E, Mononen H, Maatta R, Nieminen P, Sotaniemi KA, Myllyla VV (1999) Poststroke depression correlates with cognitive impairment and neurological deficits. Stroke 30:1875–1880CrossRef
13.
Zurück zum Zitat Kim HY (2013) Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod 38:52–54CrossRef Kim HY (2013) Statistical notes for clinical researchers: assessing normal distribution (2) using skewness and kurtosis. Restor Dent Endod 38:52–54CrossRef
14.
Zurück zum Zitat Magni E, Binetti G, Bianchetti A, Rozzini R, Trabucchi M (1996) Mini-Mental State Examination: a normative study in Italian elderly population. Eur J Neur 3:198–202CrossRef Magni E, Binetti G, Bianchetti A, Rozzini R, Trabucchi M (1996) Mini-Mental State Examination: a normative study in Italian elderly population. Eur J Neur 3:198–202CrossRef
15.
Zurück zum Zitat Measso G, Cavarzeran F, Zappalà G, Lebowitz BD, Crook TH, Pirozzolo FJ, Amaducci LA, Massari D, Grigoletto F (1993) The Mini-Mental State Examination: normative study of an Italian random sample. Dev Neuropsychol 9:77–85CrossRef Measso G, Cavarzeran F, Zappalà G, Lebowitz BD, Crook TH, Pirozzolo FJ, Amaducci LA, Massari D, Grigoletto F (1993) The Mini-Mental State Examination: normative study of an Italian random sample. Dev Neuropsychol 9:77–85CrossRef
16.
Zurück zum Zitat Medeiros, G. C., Roy, D., Kontos, N., Beach, S. R. (2020). Post-stroke depression: a 2020 updated review. General Hospital Psychiatry. Medeiros, G. C., Roy, D., Kontos, N., Beach, S. R. (2020). Post-stroke depression: a 2020 updated review. General Hospital Psychiatry.
17.
Zurück zum Zitat Nickel A, Thomalla G (2017) Post-stroke depression: impact of lesion location and methodological limitations—a topical review. Front Neur 8:498CrossRef Nickel A, Thomalla G (2017) Post-stroke depression: impact of lesion location and methodological limitations—a topical review. Front Neur 8:498CrossRef
18.
Zurück zum Zitat Pasotti, F., Magnani, F.G., Gallucci, M., Salvato, G., Ovadia, D., Scotto, M., Merolla, S., Beretta, S., Micieli, G.R., Agostoni, E.C., Beretta, G. (2020). Neuropsychological assessment in acute stroke patients. Neurological Sciences, 1–8. Pasotti, F., Magnani, F.G., Gallucci, M., Salvato, G., Ovadia, D., Scotto, M., Merolla, S., Beretta, S., Micieli, G.R., Agostoni, E.C., Beretta, G. (2020). Neuropsychological assessment in acute stroke patients. Neurological Sciences, 1–8.
19.
Zurück zum Zitat Paula JJD, Miranda DMD, Moraes END, Malloy-Diniz LF (2013) Mapping the clockworks: what does the Clock Drawing Test assess in normal and pathological aging? Arq Neuro-Psiquiatr 71:763–768CrossRef Paula JJD, Miranda DMD, Moraes END, Malloy-Diniz LF (2013) Mapping the clockworks: what does the Clock Drawing Test assess in normal and pathological aging? Arq Neuro-Psiquiatr 71:763–768CrossRef
20.
Zurück zum Zitat Quinn TJ, Elliott E, Langhorne P (2018) Cognitive and mood assessment tools for use in stroke. Stroke 49:483–490CrossRef Quinn TJ, Elliott E, Langhorne P (2018) Cognitive and mood assessment tools for use in stroke. Stroke 49:483–490CrossRef
21.
Zurück zum Zitat Robinson RG (2003) Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 54:376–387CrossRef Robinson RG (2003) Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 54:376–387CrossRef
22.
Zurück zum Zitat Robinson RG, Jorge RE (2016) Post-stroke depression: a review. Am J Psychiatry 173:221–231CrossRef Robinson RG, Jorge RE (2016) Post-stroke depression: a review. Am J Psychiatry 173:221–231CrossRef
23.
Zurück zum Zitat Robinson-Smith G, Johnston MV, Allen J (2000) Self-care self-efficacy, quality of life, and depression after stroke. Arch Phys Med Rehabil 81:460–464CrossRef Robinson-Smith G, Johnston MV, Allen J (2000) Self-care self-efficacy, quality of life, and depression after stroke. Arch Phys Med Rehabil 81:460–464CrossRef
24.
Zurück zum Zitat Spaccavento S, Craca A, Del Prete M, Falcone R, Colucci A, Di Palma A, Loverre A (2014) Quality of life measurement and outcome in aphasia. Neuropsychiatr Dis Treat 10:27–37PubMed Spaccavento S, Craca A, Del Prete M, Falcone R, Colucci A, Di Palma A, Loverre A (2014) Quality of life measurement and outcome in aphasia. Neuropsychiatr Dis Treat 10:27–37PubMed
25.
Zurück zum Zitat SPREAD – Stroke Prevention and Educational Awareness Diffusion (2016). Ictus cerebrale: Linee guida italiane di prevenzione e trattamento. VIII edizione. SPREAD – Stroke Prevention and Educational Awareness Diffusion (2016). Ictus cerebrale: Linee guida italiane di prevenzione e trattamento. VIII edizione.
26.
Zurück zum Zitat Starkstein SE, Jorge RE, Robinson RG (2010) The frequency, clinical correlates, and mechanism of anosognosia after stroke. Can J Psychiatry 55:355–361CrossRef Starkstein SE, Jorge RE, Robinson RG (2010) The frequency, clinical correlates, and mechanism of anosognosia after stroke. Can J Psychiatry 55:355–361CrossRef
27.
Zurück zum Zitat Stern RA, Arruda JE, Hooper CR, Wolfner GD, Morey CE (1997) Visual analogue mood scales to measure internal mood state in neurologically impaired patients: description and initial validity evidence. Aphasiology 11:59–71CrossRef Stern RA, Arruda JE, Hooper CR, Wolfner GD, Morey CE (1997) Visual analogue mood scales to measure internal mood state in neurologically impaired patients: description and initial validity evidence. Aphasiology 11:59–71CrossRef
28.
Zurück zum Zitat Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee (2020) Heart disease and stroke statistics—2020 update: a report from the American Heart Association. Circulation 141:e139–e596PubMed Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee (2020) Heart disease and stroke statistics—2020 update: a report from the American Heart Association. Circulation 141:e139–e596PubMed
29.
Zurück zum Zitat World Health Organization. (2002). The world health report 2002: reducing risks, promoting healthy life. World Health Organization. World Health Organization. (2002). The world health report 2002: reducing risks, promoting healthy life. World Health Organization.
Metadaten
Titel
Assessing mood and cognitive functioning in acute stroke: clinical usability of a Visual Analogue Mood Scale (VAMS)
verfasst von
Fabrizio Pasotti
Sabrina Serranò
Edoardo Nicolò Aiello
Chiara Gramegna
Matteo Querzola
Marcello Gallucci
Giuseppe Micieli
Allesandra Bollani
Elio Clemente Agostoni
Gabriella Bottini
Publikationsdatum
08.08.2021
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 3/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-021-05440-7

Weitere Artikel der Ausgabe 3/2022

Neurological Sciences 3/2022 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.